Treace Medical publishes four-year interim results from ALIGN3D study

Treace Medical (TMCI) announced the peer-reviewed publication of the four-year interim results from its ALIGN3D multicenter prospective study demonstrating positive clinical and radiographic outcomes of the Lapiplasty Procedure in the Journal of Foot & Ankle Surgery. The published results include interim data on 139 of 173 study patients treated with at least four years of follow-up from Lapiplasty in the prospective, five-year, multicenter ALIGN3D clinical study. The data showed: early return to protected weight bearing at an average of 7.7 days and return to athletic shoes at 6.5 weeks; low radiographic recurrence rates of 0.8% using HVA greater than 20 degrees and 8.4% using HVA greater than 15 degrees at 48 months; and continued significant improvement in pain and patient-reported outcome scores, including an 81% improvement in pain and 89% improvement in walking/standing on the MOxFQ scoring system through 48 months.